ClinicalTrials.gov
public full text
Public Domain
Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS
Several investigations have suggested that polyunsaturated fatty acids may promote therapeutic effects in MS. This pilot study will determine whether omega-6 polyunsaturated fatty acids (PUFAs),in the form of linoleic acid,can reduce disease activity and prevent disability progression in patients with relapsing MS.This study will seek to measure disease activity as seen on MRI scans in addition to measuring relapse rates.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control Study#1281256
- Efficacy of Diet on Quality of Life in Multiple Sclerosis#825478
- Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention#1352221
- A Study of Oxidative Pathways in MS Fatigue#1112015
- A Pilot Nutrition Program for Spinal Cord Injury and MS#1074422
Record · ID 1283124
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive